Rear-polarized Wnt5a-receptor-actin-myosin-polarity (WRAMP) Structures Promote the Speed and Persistence of Directional Cell Migration

Overview

Journal Mol Biol Cell

Specialties Cell Biology
Molecular Biology

Date 2017 Jun 9

PMID 28592632

Citations 8

Authors

Mary Katherine Connacher

Jian Wei Tay

Natalie G Ahn

Affiliations

Soon will be listed here.

Abstract

In contrast to events at the cell leading edge, rear-polarized mechanisms that control directional cell migration are poorly defined. Previous work described a new intracellular complex, the Wnt5a-receptor-actomyosin polarity (WRAMP) structure, which coordinates the polarized localization of MCAM, actin, and myosin IIB in a Wnt5a-induced manner. However, the polarity and function for the WRAMP structure during cell movement were not determined. Here we characterize WRAMP structures during extended cell migration using live-cell imaging. The results demonstrate that cells undergoing prolonged migration show WRAMP structures stably polarized at the rear, where they are strongly associated with enhanced speed and persistence of directional movement. Strikingly, WRAMP structures form transiently, with cells displaying directional persistence during periods when they are present and cells changing directions randomly when they are absent. Cells appear to pause locomotion when WRAMP structures disassemble and then migrate in new directions after reassembly at a different location, which forms the new rear. We conclude that WRAMP structures represent a rear-directed cellular mechanism to control directional migration and that their ability to form dynamically within cells may control changes in direction during extended migration.

Citing Articles

Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.

Miller S, Hoh M, Ebmeier C, Tay J, Ahn N Mol Biol Cell. 2023; 35(3):ar31.

PMID: 38117590 PMC: 10916866. DOI: 10.1091/mbc.E23-06-0255.

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

Radaszkiewicz T, Noskova M, Gomoryova K, Vondalova Blanarova O, Radaszkiewicz K, Pickova M Elife. 2021; 10.

PMID: 34702444 PMC: 8550759. DOI: 10.7554/eLife.65759.

Proteomic analysis identifies the E3 ubiquitin ligase Pdzrn3 as a regulatory target of Wnt5a-Ror signaling.

Konopelski Snavely S, Susman M, Kunz R, Tan J, Srinivasan S, Cohen M Proc Natl Acad Sci U S A. 2021; 118(25).

PMID: 34135125 PMC: 8237634. DOI: 10.1073/pnas.2104944118.

MYH9 facilitates autoregulation of adipose tissue depot development.

Cheung S, Sayeed M, Nakuluri K, Li L, Feldman B JCI Insight. 2021; 6(9).

PMID: 33986190 PMC: 8262332. DOI: 10.1172/jci.insight.136233.

Trio cooperates with Myh9 to regulate neural crest-derived craniofacial development.

Guo S, Meng L, Liu H, Yuan L, Zhao N, Ni J Theranostics. 2021; 11(9):4316-4334.

PMID: 33754063 PMC: 7977452. DOI: 10.7150/thno.51745.

References

Tovari J, Futosi K, Bartal A, Tatrai E, Gacs A, Kenessey I . Boyden chamber-based method for characterizing the distribution of adhesions and cytoskeletal structure in HT1080 fibrosarcoma cells. Cell Adh Migr. 2014; 8(5):509-16. PMC: 4594567. DOI: 10.4161/cam.28734. View

OConnell M, Fiori J, Xu M, Carter A, Frank B, Camilli T . The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene. 2009; 29(1):34-44. PMC: 2803338. DOI: 10.1038/onc.2009.305. View

Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M . Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature. 2000; 406(6795):536-40. DOI: 10.1038/35020115. View

Gao B . Wnt regulation of planar cell polarity (PCP). Curr Top Dev Biol. 2012; 101:263-95. DOI: 10.1016/B978-0-12-394592-1.00008-9. View

Michl P, Ramjaun A, Pardo O, Warne P, Wagner M, Poulsom R . CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness. Cancer Cell. 2005; 7(6):521-32. DOI: 10.1016/j.ccr.2005.05.018. View

Lei X, Guan C, Song Y, Wang H . The multifaceted role of CD146/MCAM in the promotion of melanoma progression. Cancer Cell Int. 2015; 15(1):3. PMC: 4326486. DOI: 10.1186/s12935-014-0147-z. View

Zhu H, Zhu X, Zhou M, Cheng G, Lou W . Effect of WNT5A on epithelial-mesenchymal transition and its correlation with tumor invasion and metastasis in nasopharyngeal carcinoma. Asian Pac J Trop Med. 2014; 7(6):488-91. DOI: 10.1016/S1995-7645(14)60080-8. View

Jaqaman K, Loerke D, Mettlen M, Kuwata H, Grinstein S, Schmid S . Robust single-particle tracking in live-cell time-lapse sequences. Nat Methods. 2008; 5(8):695-702. PMC: 2747604. DOI: 10.1038/nmeth.1237. View

Witze E, Litman E, Argast G, Moon R, Ahn N . Wnt5a control of cell polarity and directional movement by polarized redistribution of adhesion receptors. Science. 2008; 320(5874):365-9. PMC: 3229220. DOI: 10.1126/science.1151250. View

10.

Huttenlocher A . Cell polarization mechanisms during directed cell migration. Nat Cell Biol. 2005; 7(4):336-7. DOI: 10.1038/ncb0405-336. View

11.

Webster M, Xu M, Kinzler K, Kaur A, Appleton J, OConnell M . Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells. Pigment Cell Melanoma Res. 2014; 28(2):184-95. PMC: 4333017. DOI: 10.1111/pcmr.12330. View

12.

Schwartz M, Rogers R, Singh S, Lee J, Loveland S, Koepsel J . A quantitative comparison of human HT-1080 fibrosarcoma cells and primary human dermal fibroblasts identifies a 3D migration mechanism with properties unique to the transformed phenotype. PLoS One. 2013; 8(12):e81689. PMC: 3857815. DOI: 10.1371/journal.pone.0081689. View

13.

Krause M, Gautreau A . Steering cell migration: lamellipodium dynamics and the regulation of directional persistence. Nat Rev Mol Cell Biol. 2014; 15(9):577-90. DOI: 10.1038/nrm3861. View

14.

Iiizumi M, Liu W, Pai S, Furuta E, Watabe K . Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy. Biochim Biophys Acta. 2008; 1786(2):87-104. PMC: 2645343. DOI: 10.1016/j.bbcan.2008.07.002. View

15.

Gomez-Orte E, Saenz-Narciso B, Moreno S, Cabello J . Multiple functions of the noncanonical Wnt pathway. Trends Genet. 2013; 29(9):545-53. DOI: 10.1016/j.tig.2013.06.003. View

16.

Cramer L . Mechanism of cell rear retraction in migrating cells. Curr Opin Cell Biol. 2013; 25(5):591-9. DOI: 10.1016/j.ceb.2013.05.001. View

17.

Nishita M, Enomoto M, Yamagata K, Minami Y . Cell/tissue-tropic functions of Wnt5a signaling in normal and cancer cells. Trends Cell Biol. 2010; 20(6):346-54. DOI: 10.1016/j.tcb.2010.03.001. View

18.

Kikuchi A, Yamamoto H, Sato A, Matsumoto S . Wnt5a: its signalling, functions and implication in diseases. Acta Physiol (Oxf). 2011; 204(1):17-33. DOI: 10.1111/j.1748-1716.2011.02294.x. View

19.

Wei W, Li H, Li N, Sun H, Li Q, Shen X . WNT5A/JNK signaling regulates pancreatic cancer cells migration by Phosphorylating Paxillin. Pancreatology. 2013; 13(4):384-92. DOI: 10.1016/j.pan.2013.05.008. View

20.

Bowerman B . Cell signaling. Wnt moves beyond the canon. Science. 2008; 320(5874):327-8. PMC: 4631219. DOI: 10.1126/science.1157590. View